A special supplement on contraception and HRT has been published with the March 2022 issue of MIMS.
Contraception and menopause
A woman’s reproductive system is governed by hormones that are released from the hypothalamus, pituitary gland and ovaries.
Hormone-based contraceptives continue to be the mainstay of contraception in the UK. A woman presenting for contraception should be assessed for suitability for her desired method, with an informed discussion covering her understanding of the method and how to use it, along with details of its efficacy, risks and side-effects, and benefits and disadvantages.
When a woman reaches menopause, there should be a holistic and individualised approach to managing any menopausal symptoms she experiences, including reference to lifestyle advice, diet modification and discussion of the role of HRT.
The MIMS supplement covers:
- Overview of the menstraul cycle and menopause
- Factors affecting contraceptive choice
- Use of HRT in menopause.
The supplement is worth 1 CPD credit towards appraisal and revalidation. Claim your printed copy with the March issue of MIMS or download a digital version below.